Link2Trials Q&A_29

In this Q&A series we answer questions we have received from our customer base.

#29:

Question:
How does a patient feasibility assessment enhance diversity in clinical trials?

Answer:
Diversity in clinical trials is critical for developing treatments that work for all patient populations, yet many studies struggle to enroll diverse participants. Patient feasibility assessments help by:

• Identifying barriers to participation – Patients from different backgrounds provide insights into accessibility challenges.
• Ensuring eligibility criteria are inclusive – Some requirements may unintentionally exclude certain populations.
• Tailoring outreach strategies – Understanding how different communities prefer to receive information improves recruitment success.
• Improving cultural sensitivity in study materials – Feasibility studies ensure that language and messaging resonate with diverse audiences.
• Building trust within underrepresented communities – Engaging patients early helps address historical concerns about research participation.

By incorporating diverse patient perspectives during feasibility assessments, clinical trials become more inclusive, equitable, and effective.